Pancreatic Cancer Research

ResearcherMichigan Technological UniversityActive in the last 2 years

Xiaohu Tang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6367-4991; OpenAlex author ID A5063180505. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. Selenium-Thioredoxin Axis Contributes to Ferroptosis Resistance in Pancreatic Cancer Cells. Last author DOI 10.3390/ijms27042062↗
  2. Selenoprotein Sepp1 regulates Cysteine Dependence in Pancreatic Cancer Last author DOI 10.21203/rs.3.rs-1887450/v1↗
  3. β-Hydroxy-β-Methylbutyrate Supplementation Promotes Antitumor Immunity in an Obesity Responsive Mouse Model of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers13246359↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Arslan Amer · 2 shared papers, 2022–2026 · strength 0.62
  2. Zhengrong Cui · 1 shared paper, 2021 · strength 0.13
  3. Laura M. Lashinger · 1 shared paper, 2021 · strength 0.13
  4. Kristyn A. Liu · 1 shared paper, 2021 · strength 0.13
  5. Michael F. Coleman · 1 shared paper, 2021 · strength 0.13
  6. Stephen D Hursting · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.